Curasight AS (XSAT:CURAS) EPS (Basic) : kr-0.99 (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Curasight AS EPS (Basic)?

Curasight AS's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was kr-0.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was kr-0.99.

Curasight AS's EPS (Diluted) for the three months ended in Mar. 2025 was kr-0.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was kr-0.99.

Curasight AS's EPS without NRI for the three months ended in Mar. 2025 was kr-0.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.99.

During the past 3 years, the average EPS without NRI Growth Rate was -45.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -78.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Curasight AS's highest 3-Year average EPS without NRI Growth Rate was -45.80% per year. The lowest was -127.20% per year. And the median was -84.90% per year.

Curasight AS EPS (Basic) Historical Data

The historical data trend for Curasight AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curasight AS EPS (Basic) Chart

Curasight AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-0.18

-0.32

-0.53

-0.76

-1.00

Curasight AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															-0.23	-0.31	-0.20	-0.33	-0.14

Curasight AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Curasight AS's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-36.836	-	0)	/	36.867
	=	-1.00

Curasight AS's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.204	-	0)	/	36.250
	=	-0.14

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.99

Curasight AS (XSAT:CURAS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Curasight AS EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Curasight AS's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Curasight AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curasight AS (XSAT:CURAS) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ole Maaloes Vej 3, Kobenhavn N, Kobenhavn, DNK, DK-2200

Website

https://www.curasight.com

Curasight AS is a clinical-stage biotech company committed to improving both the diagnosis and the treatment of certain types of cancer. The company is focused on generating data with both uTRACE and uTREAT in cancers, including prostate cancer and glioblastoma (brain cancer), neuroendocrine tumors (NET), head and neck cancer, non small cell lung cancer (NSCLC), and pancreatic cancer.

Curasight AS Headlines

No Headlines